Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (8)	6/12/1997 3:40:00 PM
From: biowa	of 3044

PB, IMO, the nearest revenue prospects for any of the MLNM genes are probably in diagnostics. As you know, they retain the diagnostic rights in most of the deals and dx products are usually quicker to approval than rx. Countering that, they have yet to ANNOUNCE an effort in diagnostics, but now that they are in one deal with Affymetrix could we see a diagnostics JV? (PURE CONJECTION). Beyond that, of those we know about I would suspect metabolic disorders (probably obesity) are the nearest to some sort of clinical candidate products. BTW, you got me all excited when I logged in and saw we had a third contributor. Then you turn out to be TPFKAMB. biowa

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next